Accession Number: | 0000874015-20-000006 |
Date: | 2020-01-02 |
Issuer: | IONIS PHARMACEUTICALS INC (IONS) |
Original Submission Date: |
BENNETT C FRANK
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD, CA 92010
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 60.89 | 2020-01-02 | deemed execution date | A | 48,626 (a) | 2021-01-02 | 2027-01-01 | common stock 48,626 | $60.89 | 48,626 | direct |
ID | footnote |
---|---|
f1 | grant on 01/02/2020 to reporting person of stock options under the ionis pharmaceuticals, inc. amended and restated 2011 equity incentive plan. following this transaction, the option was exercisable as to 0 shares on 01/02/2020. 25% of the shares subject to the option will vest and become exercisable on 01/02/2021. thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years. |